CanSISE Undergraduate Internship Matthew Pittana York University Christian Haas Group.
Christian Haas Webinar July 2014
-
Upload
alzheimer-research-forum -
Category
Health & Medicine
-
view
2.213 -
download
0
description
Transcript of Christian Haas Webinar July 2014
Ludwig-Maximilians-University Munich
DZNE - German Center for Neurodegenerative Diseases, Munich & Adolf-Butenandt-Institute, Biochemistry, Ludwig-Maximilians University Munich
TREM2 – a general player in
neurodegeneration?
Christian Haass & Gernot Kleinberger
Haass, Nat. Med., 2010; Haass & Aguzzi, Science, 2003
Haass & Selkoe, Nature Reviews Mol. Cell Biology, 2007; Winklhofer, Tatzelt & Haass, EMBO J., 2008
A RIP substrate affected in several neurodegenerative
disorders: a novel common mechanism?
Prion Disorders
PrP
PD and others
a-synuclein
FTLD/ALS
TDP-
43/FUS/DP
R
AD FTLD
ta
u
Ab/tau
Regulated Intramembrane Proteolysis (RIP)
Prion Disorders PD and others FTLD-U/ALSAD FTLD
Nucleus
transcription
Trscr.
Factor
1. shedding
2. intramem.
cleavage
Haass, EMBO J, 2004
Triggering Receptor Expressed on Myeloid cells 2
(TREM2)• Attenuating inflammatory reactions
• Promoting phagocytosis
• selectively expressed in myeloid cells and microglia
• Homozygous loss-of-function mutations in TREM2
are associated with Nasu-Hakola disease / polycystic
lipomembraneous osteodysplasia (PLOSL)
• Heterozygous mutations are associated with
increased risk for late-onset AD
• Linkage to FTD-like syndrome without bone
involvement
• Linkage to FTD
• Linkage to ALS
• Linkage to PD
TREM2 variants
Shedding of TREM2 by ADAM10Gernot Kleinberger
Wunderlich et al., J Biol Chem, 2013
Kleinberger et al., Science Translational Medicine, 2014
FTD and FTD-like associated missense mutations impair TREM2
maturation and shedding
Mutations inhibit cell surface transport of TREM2
TREM2 mutations block phagocytosis(bead uptake assay in HEK 293)
TREM2 mutations block phagocytosis of E. coli(HEK 293)
TREM2 loss of function reduces phagocytosis in
primary microglia
pHrodo E.coli assay
• In accordance with reduced uptake of neuronal apoptotic cell debris upon Trem2
knockdown (Takahashi K. et al. JEM 2005)
Reduced Amyloid b-peptide uptake
Reduced levels of soluble TREM2 in CSF of
AD and FTD patients
Therapeutic modulation of TREM2 function?